15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Lucid Diagnostics Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $2.00 to $9.25 (about 4.6x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $4.19 sits 365% above the current $0.90. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.05 next quarter toward $-0.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Lucid Diagnostics Inc.
As of Jul, 4 of 4 firms rate LUCD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LUCD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.05
Range $-0.06 – $-0.04 · 4 analysts · -48% YoY
Next period, 4 analysts expect Lucid Diagnostics Inc to earn $-0.05 a share (range $-0.06 – $-0.04), versus $-0.10 a year earlier. Full-year consensus is $-0.24, growing to $-0.17 the year after.
REVENUE · NEXT QUARTER
$1.9M
Range $1.4M – $2.8M · 4 analysts · +60% YoY
Revenue is expected to reach $1.9M (range $1.4M – $2.8M), +59.6% year-over-year. Full-year consensus is $7.4M, rising to $20.1M next year.
Top analysts covering Lucid Diagnostics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LUCD.
#1
Ross Osborn
Cantor Fitzgerald · Rank #139
Buy
$3.00+232.9% to target
Overall win rate
34%
+ Follow
#2
KM
Kyle Mikson
Canaccord Genuity · Rank #192
Buy
$3.00+232.9% to target
Overall win rate
35%
+ Follow
#3
Mike Matson
Needham · Rank #204
Buy
$3.00+232.9% to target
Overall win rate
31%
+ Follow
#4
Anthony Vendetti
Maxim Group · Rank #281
Buy
$2.00+122.0% to target
Overall win rate
30%
+ Follow
#5
Edward Woo
Ascendiant Capital · Rank #358
Buy
$9.25+926.5% to target
Overall win rate
26%
+ Follow
LUCD stock forecast FAQ
What is LUCD's average 12-month price target?+
The 4 analysts with a live target average $4.19 for Lucid Diagnostics Inc over the next 12 months, ranging from a $9.25 high to a $2.00 low.
Is LUCD stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for LUCD?+
The Street-high target is $9.25 (Ascendiant Capital), and the Street-low is $2.00 (Maxim Group). The average of all 4 active targets is $4.19.
How many Wall Street analysts cover LUCD?+
4 analysts have an active rating on Lucid Diagnostics Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering LUCD?+
Among analysts who currently cover LUCD, Ross Osborn of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #139). Their current call is Buy with a $3.00 target.
What is Lucid Diagnostics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.05 per share (range $-0.06 – $-0.04) across 4 analysts. Full-year EPS is projected at $-0.24, rising to $-0.17 the following year.
How much revenue is Lucid Diagnostics Inc expected to report next quarter?+
Consensus revenue is $1.9M (range $1.4M – $2.8M). Full-year revenue is projected at $7.4M, growing to $20.1M next year.
Have analysts been upgrading or downgrading LUCD lately?+
As of Jul, 4 of 4 firms rate LUCD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LUCD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
